EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C44H69NO12 |
| Net Charge | 0 |
| Average Mass | 804.031 |
| Monoisotopic Mass | 803.48198 |
| SMILES | C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC |
| InChI | InChI=1S/C44H69NO12/c1-10-13-31-19-25(2)18-26(3)20-37(54-8)40-38(55-9)22-28(5)44(52,57-40)41(49)42(50)45-17-12-11-14-32(45)43(51)56-39(29(6)34(47)24-35(31)48)27(4)21-30-15-16-33(46)36(23-30)53-7/h10,19,21,26,28-34,36-40,46-47,52H,1,11-18,20,22-24H2,2-9H3/b25-19+,27-21+/t26-,28+,29+,30-,31+,32-,33+,34-,36+,37-,38-,39+,40+,44+/m0/s1 |
| InChIKey | QJJXYPPXXYFBGM-LFZNUXCKSA-N |
| Roles Classification |
|---|
| Biological Roles: | immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. bacterial metabolite Any prokaryotic metabolite produced during a metabolic reaction in bacteria. |
| Application: | immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| tacrolimus (anhydrous) (CHEBI:61049) has role bacterial metabolite (CHEBI:76969) |
| tacrolimus (anhydrous) (CHEBI:61049) has role immunosuppressive agent (CHEBI:35705) |
| tacrolimus (anhydrous) (CHEBI:61049) is a macrolide lactam (CHEBI:145565) |
| Incoming Relation(s) |
| tacrolimus hydrate (CHEBI:61057) has part tacrolimus (anhydrous) (CHEBI:61049) |
| IUPAC Name |
|---|
| (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone |
| INN | Source |
|---|---|
| tacrolimus | KEGG DRUG |
| Synonyms | Source |
|---|---|
| 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN | PDBeChem |
| (−)-FK 506 | ChemIDplus |
| FK 506 | KEGG COMPOUND |
| FK506 | KEGG COMPOUND |
| FK506 | KEGG COMPOUND |
| tacrolimus | ChemIDplus |
| Brand Name | Source |
|---|---|
| Prograf | ChEBI |
| Registry Numbers | Sources |
|---|---|
| Reaxys:3647477 | Reaxys |
| Reaxys:8821611 | Reaxys |
| CAS:104987-11-3 | KEGG COMPOUND |
| CAS:104987-11-3 | ChemIDplus |
| CAS:104987-11-3 | KEGG DRUG |